Guardian Capital LP Bio Rad Laboratories, Inc. Transaction History

Guardian Capital LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $884,949 - $1.24 Million	-1,687 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$708.84 - $794.68 $105,617 - $118,407	-149 Reduced 8.12%	1,687 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $110,495 - $138,729	168 Added 10.07%	1,836 $1.37 Million
Q2 2021 Aug 17, 2021	SELL	$576.64 - $649.04 $239,305 - $269,351	-415 Reduced 19.92%	1,668 $1.08 Million
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $40,478 - $49,013	74 Added 3.68%	2,083 $1.19 Million
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $6,128 - $7,721	12 Added 0.6%	2,009 $1.17 Million
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $152,688 - $179,961	336 Added 20.23%	1,997 $1.03 Million
Q2 2020 Aug 13, 2020	SELL	$334.87 - $493.06 $229,385 - $337,746	-685 Reduced 29.2%	1,661 $750,000
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $74,242 - $94,904	232 Added 10.97%	2,346 $822,000
Q4 2019 Feb 13, 2020	BUY	$319.73 - $374.2 $62,027 - $72,594	194 Added 10.1%	2,114 $782,000
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $584,736 - $662,860	1,920 New	1,920 $639,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.02B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.